20-44620200-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000022.4(ADA):c.1078+99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0555 in 1,067,310 control chromosomes in the GnomAD database, including 2,135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.073 ( 547 hom., cov: 33)
Exomes 𝑓: 0.053 ( 1588 hom. )
Consequence
ADA
NM_000022.4 intron
NM_000022.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00400
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
PKIG (HGNC:9019): (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 20-44620200-G-A is Benign according to our data. Variant chr20-44620200-G-A is described in ClinVar as [Benign]. Clinvar id is 1173012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA | NM_000022.4 | c.1078+99C>T | intron_variant | Intron 11 of 11 | ENST00000372874.9 | NP_000013.2 | ||
ADA | NM_001322051.2 | c.1006+99C>T | intron_variant | Intron 10 of 10 | NP_001308980.1 | |||
ADA | NM_001322050.2 | c.673+99C>T | intron_variant | Intron 10 of 10 | NP_001308979.1 | |||
ADA | NR_136160.2 | n.1105+99C>T | intron_variant | Intron 10 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA | ENST00000372874.9 | c.1078+99C>T | intron_variant | Intron 11 of 11 | 1 | NM_000022.4 | ENSP00000361965.4 | |||
ADA | ENST00000695995.1 | c.688+99C>T | intron_variant | Intron 8 of 8 | ENSP00000512318.1 | |||||
ADA | ENST00000695991.1 | c.616+99C>T | intron_variant | Intron 7 of 7 | ENSP00000512314.1 | |||||
ADA | ENST00000695956.1 | c.232+99C>T | intron_variant | Intron 2 of 2 | ENSP00000512285.1 | |||||
ADA | ENST00000696038.1 | n.*934C>T | non_coding_transcript_exon_variant | Exon 9 of 9 | ENSP00000512344.1 | |||||
ADA | ENST00000696038.1 | n.*934C>T | 3_prime_UTR_variant | Exon 9 of 9 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes AF: 0.0728 AC: 11075AN: 152146Hom.: 546 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
11075
AN:
152146
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0526 AC: 48167AN: 915046Hom.: 1588 AF XY: 0.0532 AC XY: 25415AN XY: 478098 show subpopulations
GnomAD4 exome
AF:
AC:
48167
AN:
915046
Hom.:
AF XY:
AC XY:
25415
AN XY:
478098
Gnomad4 AFR exome
AF:
AC:
3131
AN:
22830
Gnomad4 AMR exome
AF:
AC:
3089
AN:
43536
Gnomad4 ASJ exome
AF:
AC:
1743
AN:
22736
Gnomad4 EAS exome
AF:
AC:
20
AN:
37210
Gnomad4 SAS exome
AF:
AC:
4667
AN:
75004
Gnomad4 FIN exome
AF:
AC:
2403
AN:
52432
Gnomad4 NFE exome
AF:
AC:
30196
AN:
615788
Gnomad4 Remaining exome
AF:
AC:
2583
AN:
42352
Heterozygous variant carriers
0
2596
5192
7787
10383
12979
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0728 AC: 11091AN: 152264Hom.: 547 Cov.: 33 AF XY: 0.0717 AC XY: 5339AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
11091
AN:
152264
Hom.:
Cov.:
33
AF XY:
AC XY:
5339
AN XY:
74466
Gnomad4 AFR
AF:
AC:
0.135821
AN:
0.135821
Gnomad4 AMR
AF:
AC:
0.0561224
AN:
0.0561224
Gnomad4 ASJ
AF:
AC:
0.0783862
AN:
0.0783862
Gnomad4 EAS
AF:
AC:
0.00211946
AN:
0.00211946
Gnomad4 SAS
AF:
AC:
0.061309
AN:
0.061309
Gnomad4 FIN
AF:
AC:
0.0420041
AN:
0.0420041
Gnomad4 NFE
AF:
AC:
0.0494192
AN:
0.0494192
Gnomad4 OTH
AF:
AC:
0.0718336
AN:
0.0718336
Heterozygous variant carriers
0
533
1066
1598
2131
2664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
140
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at